The European Cardio-Oncology Guidelines recommend regular electrocardiography and troponin testing during immune checkpoint inhibitors (ICIs) treatment, but their efficacy for monitoring ICI treatment remains unclear. This study aimed to evaluate the effectiveness of a surveillance protocol for early detection of ICI-induced myocarditis.
Methods
Between May 2014 and May 2024, patients who began treatment with ICIs at our hospital and developed ICI-induced myocarditis were included in this study. We created a straightforward management flowchart for myocarditis. The protocol was based on monitoring troponin T levels. We confirmed the efficacy of our surveillance protocol using a case series of ICI-induced myocarditis.
Results
During the observation period, 3481 patients were newly started on ICIs at our hospital. Five patients were previously diagnosed with myocarditis, and five patients were diagnosed with myocarditis after the implementation of the surveillance protocol. The manual enabled the early detection of myocarditis, and the mortality rate for myocarditis at our hospital improved from 60% to 0%. The incidence of conduction system disorders significantly reduced from 100% to 0% (P < 0.01). After the surveillance protocol was initiated, there were no cases of myocarditis requiring immunosuppressive drugs beyond steroids.
Conclusions
This study confirmed the relevance of a troponin-based surveillance protocol for the early detection of ICI-induced myocarditis. The implementation of the surveillance protocol reduced mortality from myocarditis and significantly reduced serious complications of conduction system disorders. Although this study is a small case series of patients who developed myocarditis, we confirm the effectiveness of surveillance for myocarditis.
{"title":"Relevance of surveillance manual for the early detection of immune checkpoint inhibitor-induced myocarditis: A case series","authors":"Takuya Oyakawa , Nao Muraoka , Kei Iida , Ayano Fujita , Koichi Yokoyama , Hiroshi Ishikawa , Haruyasu Murakami","doi":"10.1016/j.apjon.2024.100598","DOIUrl":"10.1016/j.apjon.2024.100598","url":null,"abstract":"<div><h3>Objective</h3><div>The European Cardio-Oncology Guidelines recommend regular electrocardiography and troponin testing during immune checkpoint inhibitors (ICIs) treatment, but their efficacy for monitoring ICI treatment remains unclear. This study aimed to evaluate the effectiveness of a surveillance protocol for early detection of ICI-induced myocarditis.</div></div><div><h3>Methods</h3><div>Between May 2014 and May 2024, patients who began treatment with ICIs at our hospital and developed ICI-induced myocarditis were included in this study. We created a straightforward management flowchart for myocarditis. The protocol was based on monitoring troponin T levels. We confirmed the efficacy of our surveillance protocol using a case series of ICI-induced myocarditis.</div></div><div><h3>Results</h3><div>During the observation period, 3481 patients were newly started on ICIs at our hospital. Five patients were previously diagnosed with myocarditis, and five patients were diagnosed with myocarditis after the implementation of the surveillance protocol. The manual enabled the early detection of myocarditis, and the mortality rate for myocarditis at our hospital improved from 60% to 0%. The incidence of conduction system disorders significantly reduced from 100% to 0% (<em>P</em> < 0.01). After the surveillance protocol was initiated, there were no cases of myocarditis requiring immunosuppressive drugs beyond steroids.</div></div><div><h3>Conclusions</h3><div>This study confirmed the relevance of a troponin-based surveillance protocol for the early detection of ICI-induced myocarditis. The implementation of the surveillance protocol reduced mortality from myocarditis and significantly reduced serious complications of conduction system disorders. Although this study is a small case series of patients who developed myocarditis, we confirm the effectiveness of surveillance for myocarditis.</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.apjon.2024.100591
Jingjing He , Mengjie Shen , Xin Ye , Xiuhong Ren , Ke Chen , Jiangxu Zhang , Weijun Fan , Zhongmin Wang , Yin Xu
Co-ablation system therapy is currently in its early stages of application in tumor treatment in China. The associated protocols for perioperative management are not yet well-developed and suffer from a lack of corresponding guidelines or consensus. This study aims to improve the quality of clinical treatment and nursing care and to standardize perioperative management for patients with liver tumors undergoing co-ablation system therapy. The Committee of Ablation Therapy in Oncology, China Anti-Cancer Association, and the Committee of Interventional Perioperative, Interventional Physician Branch of the Chinese Medical Doctor Association organized medical and nursing experts in China. Based on the clinical practice of co-ablation system therapy in China and the relevant domestic literature, an expert consensus regarding perioperative management was developed. The expert consensus includes the key points of perioperative management, prevention and care of complications, discharge guidance, and follow-up management for patients who have undergone co-ablation system therapy of liver tumors. The consensus on the perioperative management of co-ablation system therapy for liver tumors has finally been formulated, providing a reference and application for medical personnel in relevant fields based on hospital and patient conditions in clinical work.
{"title":"Expert consensus on perioperative management for liver tumors treated with co-ablation system therapy","authors":"Jingjing He , Mengjie Shen , Xin Ye , Xiuhong Ren , Ke Chen , Jiangxu Zhang , Weijun Fan , Zhongmin Wang , Yin Xu","doi":"10.1016/j.apjon.2024.100591","DOIUrl":"10.1016/j.apjon.2024.100591","url":null,"abstract":"<div><div>Co-ablation system therapy is currently in its early stages of application in tumor treatment in China. The associated protocols for perioperative management are not yet well-developed and suffer from a lack of corresponding guidelines or consensus. This study aims to improve the quality of clinical treatment and nursing care and to standardize perioperative management for patients with liver tumors undergoing co-ablation system therapy. The Committee of Ablation Therapy in Oncology, China Anti-Cancer Association, and the Committee of Interventional Perioperative, Interventional Physician Branch of the Chinese Medical Doctor Association organized medical and nursing experts in China. Based on the clinical practice of co-ablation system therapy in China and the relevant domestic literature, an expert consensus regarding perioperative management was developed. The expert consensus includes the key points of perioperative management, prevention and care of complications, discharge guidance, and follow-up management for patients who have undergone co-ablation system therapy of liver tumors. The consensus on the perioperative management of co-ablation system therapy for liver tumors has finally been formulated, providing a reference and application for medical personnel in relevant fields based on hospital and patient conditions in clinical work.</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.apjon.2024.100594
Chin-Mi Chen , Heeyeon Son , Yvonne Yueh-Feng Lu , Li-Min Wu
Objective
To evaluate the reliability and validity of the spiritual perspective scale (SPS) for adolescents and young adults with cancer.
Methods
The study was conducted with 277 adolescents and young adults with cancer aged 10–24 years who were recruited from Taiwan and Korea. The reliability of the SPS was assessed using Cronbach's α. Its factor structure was determined by exploratory factor analysis. Known-group validity was tested by comparing resilience scores between two groups and between countries using t test.
Results
Cronbach's α values for the SPS was 0.94, and item–total correlation values ranged from 0.53 to 0.84. Factor analysis generated two factors (spiritual behaviors and spiritual beliefs) that explained 78.02% of the total variance, with factor loadings ranging from 0.51 to 0.94. Participants with lower resilience had significantly lower spirituality scores compared to those with higher resilience (t = 3.13, P = 0.002). The SPS scores were not significantly different between participants in Taiwan and Korea (t = 1.09, P = 0.276). However, the spiritual beliefs subscale scores did show a significant difference between these groups (t = 2.74, P = 0.007).
Conclusions
The spiritual perspective scale is a valid and reliable tool for measuring the spirituality of adolescents and young adults with cancer in Taiwan and Korea. The SPS showed sensitivity in detecting variations in spiritual beliefs between adolescents and young adults with cancer in Taiwan and Korea.
{"title":"Psychometric evaluation of the spiritual perspective scale for adolescents and young adults with cancer","authors":"Chin-Mi Chen , Heeyeon Son , Yvonne Yueh-Feng Lu , Li-Min Wu","doi":"10.1016/j.apjon.2024.100594","DOIUrl":"10.1016/j.apjon.2024.100594","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the reliability and validity of the spiritual perspective scale (SPS) for adolescents and young adults with cancer.</div></div><div><h3>Methods</h3><div>The study was conducted with 277 adolescents and young adults with cancer aged 10–24 years who were recruited from Taiwan and Korea. The reliability of the SPS was assessed using Cronbach's α. Its factor structure was determined by exploratory factor analysis. Known-group validity was tested by comparing resilience scores between two groups and between countries using <em>t</em> test.</div></div><div><h3>Results</h3><div>Cronbach's α values for the SPS was 0.94, and item–total correlation values ranged from 0.53 to 0.84. Factor analysis generated two factors (spiritual behaviors and spiritual beliefs) that explained 78.02% of the total variance, with factor loadings ranging from 0.51 to 0.94. Participants with lower resilience had significantly lower spirituality scores compared to those with higher resilience (<em>t</em> = 3.13, <em>P</em> = 0.002). The SPS scores were not significantly different between participants in Taiwan and Korea (<em>t</em> = 1.09, <em>P</em> = 0.276). However, the spiritual beliefs subscale scores did show a significant difference between these groups (<em>t</em> = 2.74, <em>P</em> = 0.007).</div></div><div><h3>Conclusions</h3><div>The spiritual perspective scale is a valid and reliable tool for measuring the spirituality of adolescents and young adults with cancer in Taiwan and Korea. The SPS showed sensitivity in detecting variations in spiritual beliefs between adolescents and young adults with cancer in Taiwan and Korea.</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.apjon.2024.100597
Geraldine A. Lee , Priya Reehal
Cardiotoxicity is a significant complication of cancer treatment, and this review describes the cardiovascular risks associated with various therapies and emphasizes the crucial role of oncology nurses in managing these risks. Many cancer treatments, including cytotoxic therapies, radiation, targeted therapies, and immune-modulatory drugs, have been shown to increase the likelihood of cardiovascular toxicity, leading to conditions such as acute coronary syndrome, heart failure, and atrial fibrillation. Guidelines are now available to reduce treatment-related cardiovascular toxicity (CTR-CVT) and stress the importance of cardiovascular assessments before, during, and after cancer treatment. Oncology nurses are pivotal in performing these assessments and collaborating within multidisciplinary teams, including cardiologists, to ensure optimal care. As more patients successfully complete cancer treatment, it becomes essential to integrate cardiovascular risk evaluation, education, and medication into routine oncology care. The evolving field of oncology nursing, particularly with the rise of emerging therapies and aging populations, requires further education on early detection and management of cardiotoxicity to enhance patient outcomes.
{"title":"Cardiotoxicity in people undergoing cancer treatment - the role of the oncology nurse","authors":"Geraldine A. Lee , Priya Reehal","doi":"10.1016/j.apjon.2024.100597","DOIUrl":"10.1016/j.apjon.2024.100597","url":null,"abstract":"<div><div>Cardiotoxicity is a significant complication of cancer treatment, and this review describes the cardiovascular risks associated with various therapies and emphasizes the crucial role of oncology nurses in managing these risks. Many cancer treatments, including cytotoxic therapies, radiation, targeted therapies, and immune-modulatory drugs, have been shown to increase the likelihood of cardiovascular toxicity, leading to conditions such as acute coronary syndrome, heart failure, and atrial fibrillation. Guidelines are now available to reduce treatment-related cardiovascular toxicity (CTR-CVT) and stress the importance of cardiovascular assessments before, during, and after cancer treatment. Oncology nurses are pivotal in performing these assessments and collaborating within multidisciplinary teams, including cardiologists, to ensure optimal care. As more patients successfully complete cancer treatment, it becomes essential to integrate cardiovascular risk evaluation, education, and medication into routine oncology care. The evolving field of oncology nursing, particularly with the rise of emerging therapies and aging populations, requires further education on early detection and management of cardiotoxicity to enhance patient outcomes.</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.apjon.2024.100593
Sirui Zhang , Limin Luo , Liqun Zhou , Lingying Ji , Baogui Deng
Objective
This study aims to analyze the classification characteristics of resilience in patients with lung cancer undergoing chemotherapy using latent profile analysis and explore the influencing factors and their relationship with medical coping strategies.
Methods
A questionnaire survey was conducted on 265 patients with lung cancer undergoing chemotherapy at a tertiary Grade-A hospital in Guangzhou from November 2023 to March 2024, using the General Information Questionnaire, Resilience Scale Specific to Cancer (RS-SC), Lung Cancer Chemotherapy Symptom Cluster Assessment Questionnaire, and Medical Coping Modes Questionnaire (MCMQ). Latent profile analysis was performed using Mplus 8.3 to identify resilience classifications, estimate influencing factors, and evaluate their impact on medical coping strategy selection.
Results
A total of 259 valid questionnaires were collected, with an effective response rate of 97.74%. Patients were categorized into three groups based on resilience levels: low-resilience group (20.46%), mid-resilience group (40.52%), and high-resilience group (38.97%). Multinomial logistic regression analysis revealed that education level, family per capita monthly income, and gastrointestinal and emotional symptom cluster scores were significant influencing factors for different resilience classifications (P < 0.05). Statistically significant differences were found in the scores for the confrontation and resignation dimensions of medical coping strategies across different latent profiles (P < 0.01).
Conclusions
Resilience in patients with lung cancer undergoing chemotherapy is heterogeneous, presenting in three distinct categories. Medical staff should provide tailored interventions based on the characteristics and influencing factors of each patient profile to enhance resilience and coping strategies.
{"title":"Latent profile analysis of resilience and its influencing factors in patients with lung cancer undergoing chemotherapy","authors":"Sirui Zhang , Limin Luo , Liqun Zhou , Lingying Ji , Baogui Deng","doi":"10.1016/j.apjon.2024.100593","DOIUrl":"10.1016/j.apjon.2024.100593","url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to analyze the classification characteristics of resilience in patients with lung cancer undergoing chemotherapy using latent profile analysis and explore the influencing factors and their relationship with medical coping strategies.</div></div><div><h3>Methods</h3><div>A questionnaire survey was conducted on 265 patients with lung cancer undergoing chemotherapy at a tertiary Grade-A hospital in Guangzhou from November 2023 to March 2024, using the General Information Questionnaire, Resilience Scale Specific to Cancer (RS-SC), Lung Cancer Chemotherapy Symptom Cluster Assessment Questionnaire, and Medical Coping Modes Questionnaire (MCMQ). Latent profile analysis was performed using Mplus 8.3 to identify resilience classifications, estimate influencing factors, and evaluate their impact on medical coping strategy selection.</div></div><div><h3>Results</h3><div>A total of 259 valid questionnaires were collected, with an effective response rate of 97.74%. Patients were categorized into three groups based on resilience levels: low-resilience group (20.46%), mid-resilience group (40.52%), and high-resilience group (38.97%). Multinomial logistic regression analysis revealed that education level, family per capita monthly income, and gastrointestinal and emotional symptom cluster scores were significant influencing factors for different resilience classifications (<em>P</em> < 0.05). Statistically significant differences were found in the scores for the confrontation and resignation dimensions of medical coping strategies across different latent profiles (<em>P</em> < 0.01).</div></div><div><h3>Conclusions</h3><div>Resilience in patients with lung cancer undergoing chemotherapy is heterogeneous, presenting in three distinct categories. Medical staff should provide tailored interventions based on the characteristics and influencing factors of each patient profile to enhance resilience and coping strategies.</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.apjon.2024.100595
Jie Zhang , Hong Yang , Yuhan Lu
In recent years, many new antitumor drugs have been approved for clinical use. Among them, antibody-drug conjugates (ADCs) are an innovative drug group that combines the advantages of chemotherapy with a cytotoxic drug and targeted therapy with monoclonal antibodies. However, although ADCs provide survival benefits to patients, their special composition and mode of action also lead to specific adverse effects. Among the common adverse effects caused by ADCs, peripheral neuropathy (PN) affects patients’ quality of life and also present significant challenges to clinical nursing. There are several guidelines and consensus for treating chemotherapy-induced peripheral neuropathy. However, there are no specific guidelines for managing PN caused by ADCs. Nurses play an important role in the prevention and management of PN, and their relevant knowledge and skills for symptom assessment, functional deficit screening, patient referral and advocacy, and patient education are indispensable. By combining Chinese and international guidelines, consensus, and related studies, this paper reviewed the occurrence and characteristics of ADC-induced PN and highlighted the principles of prevention, treatment, and nursing care to provide a reference for clinical nursing practice and improve the safety of ADCs for patients.
{"title":"Management of neurotoxic reactions induced by antibody-drug conjugates","authors":"Jie Zhang , Hong Yang , Yuhan Lu","doi":"10.1016/j.apjon.2024.100595","DOIUrl":"10.1016/j.apjon.2024.100595","url":null,"abstract":"<div><div>In recent years, many new antitumor drugs have been approved for clinical use. Among them, antibody-drug conjugates (ADCs) are an innovative drug group that combines the advantages of chemotherapy with a cytotoxic drug and targeted therapy with monoclonal antibodies. However, although ADCs provide survival benefits to patients, their special composition and mode of action also lead to specific adverse effects. Among the common adverse effects caused by ADCs, peripheral neuropathy (PN) affects patients’ quality of life and also present significant challenges to clinical nursing. There are several guidelines and consensus for treating chemotherapy-induced peripheral neuropathy. However, there are no specific guidelines for managing PN caused by ADCs. Nurses play an important role in the prevention and management of PN, and their relevant knowledge and skills for symptom assessment, functional deficit screening, patient referral and advocacy, and patient education are indispensable. By combining Chinese and international guidelines, consensus, and related studies, this paper reviewed the occurrence and characteristics of ADC-induced PN and highlighted the principles of prevention, treatment, and nursing care to provide a reference for clinical nursing practice and improve the safety of ADCs for patients.</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.apjon.2024.100596
Lixia Chen , Jia Lu , Bo Chen , Xiaoxia Zhang
<div><h3>Objective</h3><div>Patients with breast cancer who must undergo breast mastectomy are offered different types of breast reconstruction surgeries. Shared decision-making (SDM) is an important emerging intervention in the decision-making process of patients. This study aimed to evaluate the effects of SDM in patients with breast cancer undergoing breast reconstruction surgery.</div></div><div><h3>Methods</h3><div>Databases, including China National Knowledge Infrastructure, Wanfang, Chinese Biomedical Database, VIP, PubMed, Cochrane Library, Web of Science, Cumulative Index to Nursing and Allied Health Literature, and Embase, were searched for articles on the application of SDM in patients undergoing breast reconstruction. The literature search retrieval time limit was from inception to February 29, 2024, with Chinese and English language restrictions. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was used for reporting this work. The randomized controlled trial (RCT) quality was assessed using The Cochrane Collaboration's tool for assessing risk of bias and quasi-randomized trials using Joanna Briggs Institute's critical appraisal tools. The SDM effects on decisional conflict, regret, knowledge, participation, and satisfaction, anxiety, and depression were assessed. Revman5.4 software was used for the meta-analysis.</div></div><div><h3>Results</h3><div>In total, 18 papers out of 854 records identified from the database search met the eligibility criteria, including 16 articles in English and two articles in Chinese. There were 12 RCTs and six quasi-randomized trials. The meta-analysis results revealed that SDM could reduce decisional conflict [mean difference (MD), −4.49; 95% confidence interval (CI) (−6.70, −2.27); <em>P</em> < 0.001], decisional regret [MD, −6.06; 95% CI (−9.51, −2.61); <em>P</em> < 0.001], and depression [standardized mean difference (SMD), −0.67; 95% CI (−0.99, −0.35); <em>P</em> < 0.001] in patients who underwent breast reconstruction surgery. In addition, SDM can improve decisional participation [SMD, 0.30; 95% CI (0.11, 0.49); <em>P</em> = 0.002] and decisional knowledge [SMD, 0.43; 95% CI (0.11, 0.75); <em>P</em> = 0.009], but with no significant improvement in decisional satisfaction [SMD, 0.30; 95% CI (−0.35, 0.94); <em>P</em> = 0.37] and anxiety [SMD, −0.09; 95% CI (−0.22, 0.04); <em>P</em> = 0.17]. The subgroup analysis of country/region showed that the interventional effect of SDM in Western countries [MD, −3.84; 95% CI (−4.16, −3.52); <em>P</em> < 0.001] was stronger than that in Eastern countries [MD, −1.81; 95% CI (−2.32, −1.30); <em>P</em> < 0.001], and the interventional effect of Booklet group [MD, −6.92; 95% CI (−8.90, −4.94); <em>P</em> < 0.001] was stronger than that of Computer-based group [MD, −3.23; 95% CI (−3.50, −2.96); <em>P</em> < 0.001].</div></div><div><h3>Conclusions</h3><div>SDM shows positive effects in many aspects in patients with
{"title":"Effect of shared decision-making in patients with breast cancer undergoing breast reconstruction surgery: A systematic review and meta-analysis","authors":"Lixia Chen , Jia Lu , Bo Chen , Xiaoxia Zhang","doi":"10.1016/j.apjon.2024.100596","DOIUrl":"10.1016/j.apjon.2024.100596","url":null,"abstract":"<div><h3>Objective</h3><div>Patients with breast cancer who must undergo breast mastectomy are offered different types of breast reconstruction surgeries. Shared decision-making (SDM) is an important emerging intervention in the decision-making process of patients. This study aimed to evaluate the effects of SDM in patients with breast cancer undergoing breast reconstruction surgery.</div></div><div><h3>Methods</h3><div>Databases, including China National Knowledge Infrastructure, Wanfang, Chinese Biomedical Database, VIP, PubMed, Cochrane Library, Web of Science, Cumulative Index to Nursing and Allied Health Literature, and Embase, were searched for articles on the application of SDM in patients undergoing breast reconstruction. The literature search retrieval time limit was from inception to February 29, 2024, with Chinese and English language restrictions. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was used for reporting this work. The randomized controlled trial (RCT) quality was assessed using The Cochrane Collaboration's tool for assessing risk of bias and quasi-randomized trials using Joanna Briggs Institute's critical appraisal tools. The SDM effects on decisional conflict, regret, knowledge, participation, and satisfaction, anxiety, and depression were assessed. Revman5.4 software was used for the meta-analysis.</div></div><div><h3>Results</h3><div>In total, 18 papers out of 854 records identified from the database search met the eligibility criteria, including 16 articles in English and two articles in Chinese. There were 12 RCTs and six quasi-randomized trials. The meta-analysis results revealed that SDM could reduce decisional conflict [mean difference (MD), −4.49; 95% confidence interval (CI) (−6.70, −2.27); <em>P</em> < 0.001], decisional regret [MD, −6.06; 95% CI (−9.51, −2.61); <em>P</em> < 0.001], and depression [standardized mean difference (SMD), −0.67; 95% CI (−0.99, −0.35); <em>P</em> < 0.001] in patients who underwent breast reconstruction surgery. In addition, SDM can improve decisional participation [SMD, 0.30; 95% CI (0.11, 0.49); <em>P</em> = 0.002] and decisional knowledge [SMD, 0.43; 95% CI (0.11, 0.75); <em>P</em> = 0.009], but with no significant improvement in decisional satisfaction [SMD, 0.30; 95% CI (−0.35, 0.94); <em>P</em> = 0.37] and anxiety [SMD, −0.09; 95% CI (−0.22, 0.04); <em>P</em> = 0.17]. The subgroup analysis of country/region showed that the interventional effect of SDM in Western countries [MD, −3.84; 95% CI (−4.16, −3.52); <em>P</em> < 0.001] was stronger than that in Eastern countries [MD, −1.81; 95% CI (−2.32, −1.30); <em>P</em> < 0.001], and the interventional effect of Booklet group [MD, −6.92; 95% CI (−8.90, −4.94); <em>P</em> < 0.001] was stronger than that of Computer-based group [MD, −3.23; 95% CI (−3.50, −2.96); <em>P</em> < 0.001].</div></div><div><h3>Conclusions</h3><div>SDM shows positive effects in many aspects in patients with ","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.apjon.2024.100601
Yi-Chien Chiang , Shih-Hsiang Chen , Debra K. Moser , Yu-Chuan Wen , Yu-Ting Lin , Ya-Chu Hsiao
Objective
This pilot study aimed to assess the feasibility and effectiveness of an auricular acupressure intervention on sleep quality, mood state, and quality of life (QOL) among parents of children with cancer.
Methods
Thirty-five parents were assigned to three-weeks intervention in an active auricular acupressure group (AAG) or a sham auricular acupressure group (SAG). Feasibility was assessed by adherence to the acupressure protocol. Outcomes were measured using the Pittsburgh Sleep Quality Index for sleep quality, the Profile of Mood States for mood, and the QOL short form for QOL. The data were analyzed using generalized estimating equations to identify changes over time within and between the groups.
Results
Adherence to the protocol was 78%. There were no differences between the groups in overall sleep quality or mood state, but QOL in the Physical Component Summary was better in the AAG at time 1. Parents in the AAG exhibited significantly higher levels of vigor compared to those in the SAG group. Statistically significant differences were observed in the Physical Functioning and General Health subscales, with the AAG showing better outcomes than the SAG group at time 1 and time 2, respectively.
Conclusions
Likely due to the small sample size, the AAG and SAG did not differ in overall sleep quality, mood state, or QOL, but there were significant subscale differences that support intervention effectiveness. A fully powered large-scale trial is needed to determine whether this intervention would be effective for parents of children with cancer. Reducing symptom distress and improving QOL in these parents are essential, and interventions to achieve this goal must be tested.
Trial registration
ClinicalTrials.gov NCT05654155.
{"title":"Effectiveness of auricular acupressure in managing sleep quality, mood, and quality of life in parents of children with cancer: A pilot randomized controlled trial","authors":"Yi-Chien Chiang , Shih-Hsiang Chen , Debra K. Moser , Yu-Chuan Wen , Yu-Ting Lin , Ya-Chu Hsiao","doi":"10.1016/j.apjon.2024.100601","DOIUrl":"10.1016/j.apjon.2024.100601","url":null,"abstract":"<div><h3>Objective</h3><div>This pilot study aimed to assess the feasibility and effectiveness of an auricular acupressure intervention on sleep quality, mood state, and quality of life (QOL) among parents of children with cancer.</div></div><div><h3>Methods</h3><div>Thirty-five parents were assigned to three-weeks intervention in an active auricular acupressure group (AAG) or a sham auricular acupressure group (SAG). Feasibility was assessed by adherence to the acupressure protocol. Outcomes were measured using the Pittsburgh Sleep Quality Index for sleep quality, the Profile of Mood States for mood, and the QOL short form for QOL. The data were analyzed using generalized estimating equations to identify changes over time within and between the groups.</div></div><div><h3>Results</h3><div>Adherence to the protocol was 78%. There were no differences between the groups in overall sleep quality or mood state, but QOL in the Physical Component Summary was better in the AAG at time 1. Parents in the AAG exhibited significantly higher levels of vigor compared to those in the SAG group. Statistically significant differences were observed in the Physical Functioning and General Health subscales, with the AAG showing better outcomes than the SAG group at time 1 and time 2, respectively.</div></div><div><h3>Conclusions</h3><div>Likely due to the small sample size, the AAG and SAG did not differ in overall sleep quality, mood state, or QOL, but there were significant subscale differences that support intervention effectiveness. A fully powered large-scale trial is needed to determine whether this intervention would be effective for parents of children with cancer. Reducing symptom distress and improving QOL in these parents are essential, and interventions to achieve this goal must be tested.</div></div><div><h3>Trial registration</h3><div>ClinicalTrials.gov NCT05654155.</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.apjon.2024.100599
Mengjiao Xu, Linping Zhang, Mi Zhao, Suting Zhang, Ting Luo, Ying Zhu, Jing Han
Objective
To synthesize qualitative data on the role experiences of women with breast cancer as daughters, and thereby provide inspiration and reference for psychological and social interventions for these patients and their families.
Methods
Six English databases (PubMed, Web of Science, CINAHL, Embase, Cochrane Library, and Joanna Briggs Institute) and four Chinese databases (CNKI, Wanfang, VIP, and CBM) were searched from inception to June 2024 to retrieve qualitative or mixed-methods studies on the role experiences of women with breast cancer as daughters. The Joanna Briggs Institute Critical Appraisal Tool for qualitative research was used to evaluate study quality, and the results were integrated using a meta-aggregation approach.
Results
Eighteen studies were included in this meta-synthesis: 37 findings were extracted and aggregated into 10 categories and three synthesized findings. Synthesized findings focused on negative experiences in the role of daughter; positive experiences in the role of daughter; and support needs in the role of daughter. The confidence of all synthesized findings was moderate.
Conclusions
Emphasis should be placed on the role experiences of women with breast cancer as daughters, and targeted practical assistance and professional support should be provided to promote the stable development of the patient’s relationship with their parents and enhance the coping ability of both patients and their families.
Systematic review registration
PROSPERO, CRD42023456567.
{"title":"Role experiences of women with breast cancer as daughters: A qualitative meta-synthesis","authors":"Mengjiao Xu, Linping Zhang, Mi Zhao, Suting Zhang, Ting Luo, Ying Zhu, Jing Han","doi":"10.1016/j.apjon.2024.100599","DOIUrl":"10.1016/j.apjon.2024.100599","url":null,"abstract":"<div><h3>Objective</h3><div>To synthesize qualitative data on the role experiences of women with breast cancer as daughters, and thereby provide inspiration and reference for psychological and social interventions for these patients and their families.</div></div><div><h3>Methods</h3><div>Six English databases (PubMed, Web of Science, CINAHL, Embase, Cochrane Library, and Joanna Briggs Institute) and four Chinese databases (CNKI, Wanfang, VIP, and CBM) were searched from inception to June 2024 to retrieve qualitative or mixed-methods studies on the role experiences of women with breast cancer as daughters. The Joanna Briggs Institute Critical Appraisal Tool for qualitative research was used to evaluate study quality, and the results were integrated using a meta-aggregation approach.</div></div><div><h3>Results</h3><div>Eighteen studies were included in this meta-synthesis: 37 findings were extracted and aggregated into 10 categories and three synthesized findings. Synthesized findings focused on negative experiences in the role of daughter; positive experiences in the role of daughter; and support needs in the role of daughter. The confidence of all synthesized findings was moderate.</div></div><div><h3>Conclusions</h3><div>Emphasis should be placed on the role experiences of women with breast cancer as daughters, and targeted practical assistance and professional support should be provided to promote the stable development of the patient’s relationship with their parents and enhance the coping ability of both patients and their families.</div></div><div><h3>Systematic review registration</h3><div>PROSPERO, CRD42023456567.</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.apjon.2024.100592
Ni Yang , Yuan Xu , Haoran Shi , Jianhua Sun , Yufen Ma , Shuli Guo , Ying Liu , Ranxun An , Xinyi Zhou
Objective
To summarize the best evidence related to perioperative non-pharmacologic prophylaxis of venous thromboembolism in patients with pancreatic cancer, and improve the quality of clinical practice.
Methods
According to the “6S” evidence pyramid model, we searched guideline networks, professional society websites, and comprehensive databases for clinical decisions, clinical guidelines, expert consensus, evidence summaries, and systematic reviews related to perioperative non-pharmacological prophylaxis of venous thromboembolism in patients with pancreatic cancer. The literature quality assessment followed appropriate tools. If there were any conflicts about the conclusions drawn from different sources of evidence, this study followed the principle of high-quality evidence and the latest published authoritative literature priority. The “JBI Evidence Pre-grading and Evidence Recommendation Level System 2014” was adopted for the evidence lacking a grading system.
Results
Nineteen studies were included, including 7 guidelines, 5 expert consensus, 2 clinical decisions, 3 evidence summaries, and 2 systematic reviews. Twenty-three pieces of best evidence were summarized in five aspects: risk assessment, mechanical prophylactic devices, initiation and duration of non-pharmacological prevention, implementation strategies, and health education.
Conclusions
The 23 pieces of evidence in five aspects we summarized provide scientific references for clinical caregivers to develop perioperative venous thromboembolism prophylaxis for pancreatic cancer patients. In addition, in order for evidence to be effectively used to improve the quality of clinical practice, clinical caregivers should consider patient preferences and explore barriers to the evidence translation and application.
Systematic review registration
This study has been registered on the Fudan University Centre for Evidence-based Nursing (Registation No. ES20233506).
{"title":"Evidence summary on perioperative non-pharmacological prophylaxis of venous thromboembolism in patients with pancreatic cancer","authors":"Ni Yang , Yuan Xu , Haoran Shi , Jianhua Sun , Yufen Ma , Shuli Guo , Ying Liu , Ranxun An , Xinyi Zhou","doi":"10.1016/j.apjon.2024.100592","DOIUrl":"10.1016/j.apjon.2024.100592","url":null,"abstract":"<div><h3>Objective</h3><div>To summarize the best evidence related to perioperative non-pharmacologic prophylaxis of venous thromboembolism in patients with pancreatic cancer, and improve the quality of clinical practice.</div></div><div><h3>Methods</h3><div>According to the “6S” evidence pyramid model, we searched guideline networks, professional society websites, and comprehensive databases for clinical decisions, clinical guidelines, expert consensus, evidence summaries, and systematic reviews related to perioperative non-pharmacological prophylaxis of venous thromboembolism in patients with pancreatic cancer. The literature quality assessment followed appropriate tools. If there were any conflicts about the conclusions drawn from different sources of evidence, this study followed the principle of high-quality evidence and the latest published authoritative literature priority. The “JBI Evidence Pre-grading and Evidence Recommendation Level System 2014” was adopted for the evidence lacking a grading system.</div></div><div><h3>Results</h3><div>Nineteen studies were included, including 7 guidelines, 5 expert consensus, 2 clinical decisions, 3 evidence summaries, and 2 systematic reviews. Twenty-three pieces of best evidence were summarized in five aspects: risk assessment, mechanical prophylactic devices, initiation and duration of non-pharmacological prevention, implementation strategies, and health education.</div></div><div><h3>Conclusions</h3><div>The 23 pieces of evidence in five aspects we summarized provide scientific references for clinical caregivers to develop perioperative venous thromboembolism prophylaxis for pancreatic cancer patients. In addition, in order for evidence to be effectively used to improve the quality of clinical practice, clinical caregivers should consider patient preferences and explore barriers to the evidence translation and application.</div></div><div><h3>Systematic review registration</h3><div>This study has been registered on the Fudan University Centre for Evidence-based Nursing (Registation No. ES20233506).</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}